Towards Healthcare
Nucleic Acid Storage System Market Trends and Companies

Nucleic Acid Storage System Market Demand Rises in Biobanks 2025

The market is experiencing strong growth due to the rising demand for molecular diagnostics, increasing genomic research, and advancements in personalized medicine. North America dominated the market, supported by its advanced healthcare infrastructure, growing investments in biotechnology, and early adoption of innovative diagnostic technologies.

  • Last Updated: 24 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The nucleic acid storage system market expected to reach hundreds of millions in revenue by 2034, driven by rising demand and technological advancements.

North America is currently leading the nucleic acid storage system market share by 35% due to its well-established research infrastructure, extensive biobanking facilities, and strong government support for biotechnology initiatives.

Azenta Life Sciences, Hamilton Company, Stirling Ultracold, PHCbi (PHC Corporation Panasonic Healthcare), Avantor (VWR Avantor), Merck KGaA MilliporeSigma, Beckman Coulter (Danaher), Zymo Research 

Key trends include the growth due to the rising demand for molecular diagnostics, increasing genomic research, and advancements in personalized medicine.

Common formats include microcentrifuge tubes, vials, ampoules, and lyophilized powders. 

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.